Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Multicenter Randomized Trial of Bevacizumab in Metastatic Breast Cancer
2006-006507-36Phase 3Completed
- Sponsor
- Genentech
- Start
- Feb 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of bevacizumab in breast cancer, sponsored by Genentech. Primary endpoint: Progression-Free Survival. Started Feb 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2006-006507-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006507-36.